We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

271 hedge funds and large institutions have $4.27B invested in Bio-Rad Laboratories Class A in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 81 increasing their positions, 119 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $2.8M | Put options by funds: $1.29M

1.45% more ownership

Funds ownership: 76.8% → 78.25% (+1.4%)

0% more capital invested

Capital invested by funds: $4.26B → $4.27B (+$9.01M)

9% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 33

2% less funds holding

Funds holding: 276 → 271 (-5)

32% less repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 119

40% less funds holding in top 10

Funds holding in top 10: 10 → 6 (-4)

Holders
271
Holders Change
-5
Holders Change %
-1.81%
% of All Funds
6.76%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.15%
New
30
Increased
81
Reduced
119
Closed
33
Calls
$2.8M
Puts
$1.29M
Net Calls
+$1.51M
Net Calls Change
+$1.44M

Top Buyers

1
American Century Companies
American Century Companies
Missouri
+$127M
2
Bank of America
Bank of America
North Carolina
+$38.3M
3
PC
Polar Capital
United Kingdom
+$30.4M
4
SC
Samlyn Capital
New York
+$25.9M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$22.5M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$124M
2
AA
Antipodean Advisors
New York
-$17M
3
ACM
Atlanta Capital Management
Georgia
-$16.1M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$15M
5
BCM
BlueCrest Capital Management
Jersey
-$13.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
26
Hermes Investment Management
United Kingdom
$43.1M -$1.52M -6,744 -3%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$38.7M +$570K +2,534 +1%
Norges Bank
28
Norges Bank
Norway
$38.7M -$1.96M -8,709 -5%
Fidelity Investments
29
Fidelity Investments
Massachusetts
$35.2M -$124M -552,960 -78%
TM
30
Tikvah Management
North Carolina
$30.7M – – –
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$30.6M +$1.88M +8,352 +6%
PC
32
Polar Capital
United Kingdom
$30M +$30.4M +135,195 New
Neuberger Berman Group
33
Neuberger Berman Group
New York
$29.2M +$4.96M +22,050 +20%
Charles Schwab
34
Charles Schwab
California
$26.3M +$744K +3,304 +3%
SC
35
Samlyn Capital
New York
$25.6M +$25.9M +114,984 New
EARNEST Partners
36
EARNEST Partners
Georgia
$25.5M -$553K -2,458 -2%
SGA
37
Sector Gamma AS
Norway
$24.3M -$1.24M -5,502 -5%
RA
38
Royce & Associates
New York
$23.5M -$878K -3,900 -4%
Goldman Sachs
39
Goldman Sachs
New York
$22.7M -$976K -4,339 -4%
Adage Capital Partners
40
Adage Capital Partners
Massachusetts
$22.2M +$11.2M +49,978 +100%
Westfield Capital Management
41
Westfield Capital Management
Massachusetts
$22.2M +$22.5M +99,788 New
PAMP
42
Polar Asset Management Partners
Ontario, Canada
$21.6M +$8.84M +39,300 +68%
Russell Investments Group
43
Russell Investments Group
United Kingdom
$21.5M -$2.28M -10,141 -9%
NFA
44
Nationwide Fund Advisors
Ohio
$21.4M +$1.09M +4,856 +5%
PPA
45
Parametric Portfolio Associates
Washington
$21.3M -$569K -2,530 -3%
TCIM
46
TIAA CREF Investment Management
New York
$20.4M +$466K +2,071 +2%
Renaissance Technologies
47
Renaissance Technologies
New York
$20.1M +$923K +4,100 +5%
HP
48
Hosking Partners
United Kingdom
$19.5M +$83.5K +371 +0.4%
Principal Financial Group
49
Principal Financial Group
Iowa
$19.2M -$569K -2,528 -3%
Franklin Resources
50
Franklin Resources
California
$19.2M -$4.82M -21,400 -20%
1
2
3 4 5

BIO Hedge Fund Activity: Q3 2017 in Review

271 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2017, worth a combined $4.27B — up 0.21% from $4.26B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of BIO and 30 opened new positions — a net loss of 3 holders — while 119 trimmed existing stakes and 81 added.

The largest buyer was American Century Companies, opening a new position worth an estimated $127M. The largest seller was Fidelity Investments, cutting an estimated $124M.

  • 271 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2017, down from 276 in Q2 2017.
  • Funds reported $4.27B of Bio-Rad Laboratories Class A stock for Q3 2017, up 0.21% quarter-over-quarter.
  • 30 funds opened new Bio-Rad Laboratories Class A positions in Q3 2017 and 33 closed out, a net change of -3 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2017 was American Century Companies, an estimated $127M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2017 was Fidelity Investments, an estimated $124M sold.

Based on aggregated 13F filings for Q3 2017.